Methods for predicting drug sensitivity in patients afflicted with an inflammatory disease

    公开(公告)号:US07148008B2

    公开(公告)日:2006-12-12

    申请号:US10234652

    申请日:2002-09-03

    申请人: Hakon Hakonarson

    发明人: Hakon Hakonarson

    IPC分类号: C12Q1/68

    摘要: Methods are disclosed for predicting the efficacy of a drug for treating an inflammatory disease in a human patient, including: obtaining a sample of cells from the patient; obtaining a gene expression profile of the sample in the absence and presence of in vitro modulation of the cells with specific cytokines and/or mediators; and comparing the gene expression profile of the sample with a reference gene expression profile, wherein similarities between the sample expression profile and the reference expression profile predicts the efficacy of the drug for treating the inflammatory disease in the patient.

    Compositions and methods for treatment of asthma
    6.
    发明授权
    Compositions and methods for treatment of asthma 有权
    用于治疗哮喘的组合物和方法

    公开(公告)号:US06630140B1

    公开(公告)日:2003-10-07

    申请号:US09261104

    申请日:1999-03-03

    IPC分类号: A61K39395

    摘要: Methods of treating or preventing induction of asthma in a human patient are provided. The methods comprise administering to the human an anti-Fc&egr;RII receptor protein ligand suspended in a pharmaceutically acceptable carrier in an amount sufficient to inhibit binding of IgE to an anti-Fc&egr;RII receptor protein thereby treating or preventing induction of asthma in the human.

    摘要翻译: 提供了治疗或预防人类患者哮喘诱导的方法。 所述方法包括以足以抑制IgE与抗FcepsilRII受体蛋白结合从而治疗或预防人类诱发哮喘的量向悬浮在药学上可接受的载体中的人施用抗FcepsilRII受体蛋白质配体。